ASKA launches Irinotecan from Actavis in Japan Reuters Tokyo-Zug, 8 February 2012 - ASKA has announced the launch of Irinotecan, the first oncology product from Actavis in Japan. This product is the anticancer agent which inhibits the topoisomerase I, and ASKA obtained the marketing approval on 15 July ...
Aska sugar factory resumes operation in Odisha odishatoday.com By Our correspondent Aska : The Aska Cooperative Sugar Industries (ACSIL) resumed operation today 12 days after being closed following the collapse of its molasses tank which killed three persons. "The sugar factory re-started its processing from ...
Generic launches of irinotecan, Primaxin and Merrem The Pharma Letter Japan's ASKA Pharmaceuticals has announced the launch of irinotecan, the active ingredient of Campto (originated by Rhone-Poulenc, now a Sanofi legacy company), the first oncology product from Icelandic generics group Actavis in Japan.